Articles of the Month
Videos
Allergy Ranks Highest Impact Factor in Allergy
We are thrilled to announce that the 2024 journal Impact Factors stablished by Clarivate has been released, and we are immensely proud to share that Allergy has been recognised with a Impact Factor of 12.6 as the number one journal in our speciality of Allergy and Clinical Immunology. This outstanding achievement is a testament to the entire team's unwavering commitment and hard work.
The success of Allergy is rooted in several key factors:
Full Commitment and Hard Work: The dedication of our editorial and support teams has been instrumental in driving the journal to new heights.
Rapid Decisions for Submissions: Our efficient submission process ensures that authors receive timely and comprehensive feedback.
Extensive and High-Quality Reviews: We maintain rigorous peer review standards to ensure the publication of only the highest quality research.
Timely Publications: Speedy yet thorough processing of manuscripts guarantees that important research reaches the community promptly.
High Numbers of Impressions and Downloads: The significant engagement with our published papers highlights the journal’s influence and reach within the scientific community.
On behalf of the EAACI Executive Committee, it is our pleasure to extend our heartfelt gratitude to the entire Allergy team.
Special thanks to our Editor-in-Chief, Cezmi Akdis, for his visionary leadership, and our Deputy Editors, Ioana Agache and Marek Jutel, for their invaluable contributions. We also recognize the vital roles of our Associate Editors, including Heimo Breiteneder, Thomas Eiwegger, Wytske Fokkens, Emma Guttman-Yassky, David Jackson, Kari Nadeau, Robyn O’Hehir, Liam O’Mahony, Oliver Pfaar, Alexandra Santos, Claudia Traidl-Hoffmann, De Yun Wang, and Luo Zhang, along with the entire editorial board for their expertise and dedication.
In addition, our heartfelt thanks go to our Managing Editor, Laura Alberch; Graphics Editor, Anna Globinska; Social Media Editor, Ruya Kilic Ogulur; Associate Managing Editor, Marisa McGarry; Production Editor, Sathish Asokan Kannan, and Journal’s Publishing Manager, Lisbeth Cranfield.
Together, we have set a new standard of excellence in Allergy and Clinical Immunology, and we look forward to continuing this upward trajectory. Thank you to everyone who has contributed to making #Allergy a leader in our field!
Maria Torres
EAACI President
Articles
Tissue levels of Alternaria allergen Alt a 1 reflect recurrence of refractory airway diseases
Miyabe, Y., Abe, T., Yamada, T., et al. Allergy. First published: 07 September 2024
Association of cytotoxic effector memory CD8+ T cells with sustained unresponsiveness after peanut oral immunotherapy
Seastedt, H., Han, X., Fernandes, A., et al. Allergy. First published: 07 September 2024
Reply to correspondence to “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
Bager, P., Wohlfahrt, J. and Melbye, M. Allergy. First published: 03 September 2024
Asthma development is associated with low mucosal IL-10 during viral infections in early life
Melgaard ME, Jensen SK, Eliasen A, et al. Allergy. First published: 02 September 2024
Thunderstorm-related respiratory symptoms: An old story with a new ending?
Thien, F., Annesi-Maesano, I. and D'Amato, G. Allergy. First published: 02 September 2024
Basophil activation test is a complementary tool in the diagnosis of immediate reactions to platinum salts and taxanes
Bogas G, Ariza A, Vázquez-Revuelta P, et al. Allergy. First published: 31 August 2024
Potential and limitations of the human mast cell activation test in amoxicillin hypersensitivity
Ebo, D.G., Bahri, R., Tontini, C., et al. Allergy. First published: 31 August 2024
Transcriptomic in allergy–statistical recommendations
Ordak, M., Di Bona, D. and Serviddio, G. Allergy. First published: 31 August 2024
Global burden of vaccine-associated angioedema and their related vaccines, 1967–2023: Findings from the global pharmacovigilance database
Jeong, Y.D., Lee, K., Park, J., et al. Allergy. First published: 30 August 2024
MiR-10b-5p alleviates Th2 inflammatory response by targeting SHP2 phosphatase in allergic rhinitis
Li, Y., Zhao, X., Liu, Z., et al. Allergy. First published: 29 2024
Subcutaneous adipose tissue: Implications in dermatological diseases and beyond
Ziadlou R, Pandian GN, Hafner J, et al. Allergy. First published: 29 August 2024
Maternal allergy-preventive diet index, offspring infant diet diversity, and childhood allergic diseases
Venter C, Pickett-Nairne K, Leung D, et al. Allergy. First published: 28 August 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic response
Bachmann MF, Krenger PS, Mohsen MO, et al. Allergy. First published: 27 August 2024
Aspirin hypersensitivity diagnostic index (AHDI): In vitro test for diagnosing of N-ERD based on urinary 15-oxo-ETE and LTE4 excretion
Mastalerz L, Trąd G, Szatkowski P, et al. Allergy. First published: 23 August 2024
Allergen immunotherapy adverse events in adults with respiratory allergies-data from ADER: An EAACI task force report
Julijana A, Dimitrios M, George K, et al. Allergy. First published: 22 August 2024
Algorithms in allergy: An algorithm for alpha-Gal syndrome diagnosis and treatment, 2024 update
Darsow, U., Gelincik, A., Jappe, U., et al.Allergy. First published: 22 August 2024
Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population-based cohort study
Tsai S-C, Gaffin JM, Hawryluk EB, et al. Allergy. First published: 21 August 2024
An algorithm for the diagnosis and treatment of eosinophilic esophagitis in adults, 2024 update
Pfefferlé, M. and Greuter, T.Allergy. First published: 21 August 2024
Paediatric hospitalizations due to allergic reactions increasing in Finland and decreasing in Sweden
Saarimäki, L., Ekström, S., Protudjer, J.L.P., et al. Allergy. First published: 21 August 2024
NRP1 antagonism as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis
Khalmuratova R, Ryu J-S, Hwang JH, et al.Allergy. First published: 21 August 2024
Multimodal profiling of biostabilized human skin modules reveals a coordinated ecosystem response to injected mRNA-1273 COVID-19 vaccine
Scholaert M, Peries M, Braun E, et al. Allergy. First published: 19 August 2024
Infantile colic is associated with development of later constipation and atopic disorders
Stokholm J, Thorsen J, Schoos A-M, et al. Allergy. First published: 19 August 2024
Biomarkers for a less invasive strategy to predict children with eosinophilic esophagitis
Thulin H, Mansouri L, Altman M, et al. Allergy. First published: 19 August 2024
Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function
Angelina, A., Pérez-Diego, M. and Palomares, O. Allergy. First published: 19 August 2024
Higher levels of basal serum tryptase are associated with sensitization, FeNO, allergic morbidity, and lower control of allergic asthma in teenagers from the PARIS birth cohort
Chantran, Y., Choi, S., Roda, C., et al. Allergy. First published: 19 August 2024
Comparison of two different pollen season definitions based on 10 years of birch and grass pollen data from two distant central European cities: An EAACI Task Force report
Pfaar, O., Bastl, M., Berger, M., et al. Allergy. First published: 16 August 2024
Recent patents in allergy and immunology: The interleukin-2 receptor pathway agonist rezpegaldesleukin (REZPEG) for the rescue of regulatory T cells in chronic inflammatory and autoimmune diseases
Fanton, C. and Zalevsky, J. Allergy. First published: 16 August 2024
Type 2 memory B cells: The repository of allergic memory?
Mulder, J., Dvorscek, A.R. and Ding, Z.Allergy. First published: 16 August 2024
Indirect case-matched comparison of anti-IL4Rα versus anti-IL5Rα on airway hyperresponsiveness
Chan, R., Stewart, K., Kuo, C.R. and Lipworth, B.Allergy. First published: 16 August 2024
Proposed amendment to the nomenclature of allergic diseases and hypersensitivity reactions: Looking beyond the classic paradigms
Mastalerz, L. Allergy. First published: 16 August 2024
Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma
Jabeen MF, Sanderson ND, Tinè M, et al.Allergy. First published: 11 August 2024
Assessment of sIgE to rLep d 2 for detecting Lepidoglyphus destructor sensitization
Martin-Garcia, C., Murillo-Casas, A.D., Lázaro-Sastre, M.,et al.Allergy. First published: 11 August 2024
Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma
Fricker M, Harrington J, Hiles SA, Gibson PG. Allergy. First published: 08 August 2024
Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
Kim M, Del Duca E, Dahabreh D, et al. Allergy. First published: 08 August 2024
Transcriptomic profiles of well-differentiated airway epithelial cells in response to environmental triggers of asthma exacerbation
Marrocco, A., Mitchel, J.A., Parker, M., et al.Allergy. First published: 07 August 2024
Impact of a drug allergy education course for non-specialists: Findings from ADAPT—A randomized crossover trial
Lucas M, Mak HWF, Lee JTY, Kulkarni R, Chan SSC, Li PH. Allergy. First published: 07 August 2024
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration
Traidl-Hoffmann C, Afghani J, Akdis C, et al.Allergy. First published: 04 August 2024
IgE glycosylation and impact on structure and function: A systematic review
McCraw AJ, Palhares LCGF, Hendel JL, et al.Allergy. First published: 04 August 2024
Two-year post-treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy-003 Long-Term (PPOIT-003LT) study
Loke P, Wang X, Lloyd M, et al.Allergy. First published: 04 August 2024
Children with elevated wheat IgG4 antibody titer in autism spectrum disorder: Clinical presentation and findings associated with gut microbiota
Tian, Y., Luo, X., Chen, J., et al.Allergy. First published: 02 August 2024
Key factors that influence quality of life in patients with IgE-mediated food allergy vary by age
Kubala SA, Young FD, Callier V, et al.Allergy. First published: 02 August 2024
Proton pump inhibitor effect on esophageal protein signature of eosinophilic esophagitis, prediction, and evaluation of treatment response
Molina-Jiménez F, Ugalde-Triviño L, Arias-González L, et al.Allergy. First published: 02 August 2024
Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
Rupani H, Busse WW, Howarth PH, et al.Allergy. First published: 01 August 2024
Trajectories of egg sensitization in childhood: Two birth cohorts in Asia and Europe
Nakamura T, Nakano T, Simpson A, et al.Allergy. First published: 01 August 2024
Citations: 342
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 147
EAACI guidelines: Anaphylaxis (2021 update)
Muraro A, Worm M, Alviani C, et al. Allergy. 2022; 77: 357–377
Citations: 118
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Maurer M, Magerl M, Betschel S, et al. Allergy. 2022; 77: 1961–1990
Citations: 118
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 114
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, et al. Allergy. 2022; 77: 1418–1449
Citations: 105
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 92
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., et al. Allergy. 2021; 76: 3307-3313
Citations: 90
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 88/h5>
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji MH, Valenta R, Jardetzky T, et al. Allergy. 2021; 76: 3627–3641
Citations: 82
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 81
Advances and highlights in allergic rhinitis
Zhang Y, Lan F, Zhang L. Allergy. 2021; 76: 3383–3389
Citations: 79
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 76
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 74
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Citations: 73
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Allergy. 2022; 77: 812–826
Citations: 70
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 69
Advances and highlights in biomarkers of allergic diseases
Ogulur I, Pat Y, Ardicli O, et al. Allergy. 2021; 76: 3659–3686
Citations: 69
Regulatory B cells, A to Z
Jansen, K., Cevhertas, L., Ma, S., Satitsuksanoa, P., Akdis, M. and van de Veen, W.
Citations: 62
Advances and highlights in asthma in 2021
Agache I, Eguiluz-Gracia I, Cojanu C, et al. Allergy. 2021; 76: 3390–3407
Citations: 62
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Citations: 61
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 2022; 77: 83-99
February 2023 - Food Allergy and Allergic/Inflammatory Gastrointestinal Diseases
Volume 78 | Issue 2
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Junior Members Corner
Dear Junior Members,
The EAACI Summer symposium on Epithelial Cell Biology was held at the Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland, from July 25-26, 2024. During 2 exciting days, we attended different sessions by renowned speakers from different parts of the world with impressive talks on the epithelial barrier of the skin, gut and airway, metabolism, microbiome and their associated diseases.
Moreover, vibrant discussions were held during the 4 poster sessions, where most of the juniors presented more than 20 different posters that allowed us to learn and enrich ourselves while having informal discussions with the faculties and young colleagues. Of great importance was the networking activity during the lunch break on the first day, where we enjoyed a wonderful “lake walk with the experts” in which junior and seniors spent a pleasant time getting to know each other while enjoying a wonderful sunny midday.
We would like to take the opportunity to introduce the new EAACI Junior Member Assembly (JMA) for the next term 2024-2026, which has been elected after the annual congress. We welcome new members: Jitesh Chauhan (Basic and Clinical Immunology Section), Ozge Can Bostan (Asthma Section), Polina Pyatilova (Dermatology section), Fabio Ryser (ENT section), Bianca Olivieri (Food Allergy IG), Martha Jimenez Freites (Allergy immunotherapy IG), Gonçalo Silva (Environmental and occupational allergy IG), and Pedro Alves (Allied health and primary care IG), who joined previous board members: Ekaterina Khaleva (Paediatrics section), Riccardo Castagnoli (Allergy Diagnosis and systems medicine IG), Marina Labella (Drug Allergy IG), and Aspasia Karavelia, Ruben Fernandez-Santamaria and Leticia de las Vecillas, the new chair, the secretary and the past chair. We are very excited and looking forward to continue or even improve the current and future projects totally oriented to EAACI junior members.
Best regards,
The Junior Member Assembly
EAACI Patients Organisation Committee Corner
The POC Reunion in the Annual Congress 2023
The POC has been participating in the EAACI Annual Congresses and focused meetings such as FAAM and PAAM since 2011. When Covid-19 pandemic and strict public health measures started in 2020, POC members continued attending the EAACI events virtually. For the first time in a long while, the POC returned to in-person participation in the Annual Congress Hamburg 2023.
Fifteen members of the committee attended the Annual Congress 2023 in-person. The special session ESS1 which was completely organised by the POC took place on the first day of the Congress with great success. Session was designed to discuss the “Benefits of engaging with patients in clinical trials and decision-making” with different stakeholders.
Giulia Gabrielli from European Medicine Agency (EMA) shared the framework for engagement between the Agency and the patients. Dr Kirsten Perrett, Director of Australia National Allergy Centre of Excellence, shared their experience in receiving the federal funding for allergy prevention and management in collaboration with the POC member Allergy & Anaphylaxis Australia. Susanna Palkonen, Director of European Federation of Allergy and Airways Diseases Patients Associations (EFA) presented their long-lasting track record in participation to research projects. POC Member Mikaela Odemyr, President of Asthma and Allergy Association Sweden shared her experience as a patient representative in participating the research design and planning process.
The session chairs were Carla Jones, CEO of Allergy UK, past POC Co-Chair and Ozlem Ceylan, President of Living with Allergy Association, current POC Chair. The session also had a panel discussion where chairs invited the audience to share their experiences and best practises.
Additionally, POC members Sabine Schnadt (DAAB-Germany) presented “Managing the risk of patients with peanut allergy: the value of thresholds of reaction” in the industry session, Patricia Carmelo and Carolina Olivares (Fundacion Creciendo con Alergias Alimenarias-Chile) had two poster presentations; “Food Allergens that trigger anaphylaxis in children in Chile” and “Adrenaline Auto-injector in Chile, National Survey 2020”.
Several POC members attended the Beat Allergy Run & Walk on the 10th of June. The event was organised to contribute on providing much-needed aid as the collected funds were sent to those affected by the earthquakes in Turkey.
The POC believes the conferences and in-person meetings are useful in staying up to date with new developments in medicine, dissemination of knowledge, enabling interaction with opinion leaders, networking, developing consensus, and adoption of newer ideas relevant to the patient community. Going forward, committee members consider hybrid conventions a decent opportunity to increase accessibility and inclusivity. In 2024, POC is planning to attend the Annual Congress in Valencia and FAAM in Athens.
